6864.Two

The company's capital structure is characterized by a high proportion of equity, with total equity of 510,493,000 TWD and total liabilities of 9,917,000 TWD, resulting in a debt-to-equity ratio of 0.0. The liquidity position is marked by a current ratio of 47.84, indicating strong short-term liquidity. However, the company has negative net cash after subtracting total debt, which is a key liquidity flag.

Profitability metrics show a challenging financial position, with a return on equity of -18.33% and a return on assets of -17.99%. The company reported a net loss of 93,597,000 TWD and an operating loss of 95,985,000 TWD, indicating significant operational challenges. The gross profit of 326,000,000 TWD is insufficient to cover operating expenses, contributing to the negative returns.

The company's revenue is concentrated in a single segment, as disclosed in the financial snapshot, with no specific geographic breakdown provided. This lack of diversification may pose a risk to the company's stability, especially in a volatile industry like healthcare diagnostics.

The growth trajectory is negative, with the company reporting a net loss and negative operating cash flow. The outlook for the current fiscal year is not provided, but the negative financial performance suggests a challenging growth path. The company's capital expenditure of -6,836,000 TWD indicates a reduction in investment, which may affect long-term growth potential.

Risk factors include liquidity concerns due to negative net cash and the potential for dilution, although the risk of dilution is currently assessed as low. The company's financial performance and negative cash flows may necessitate future financing, which could lead to dilution of existing shareholders.

Recent events and filings have not been provided in the available data, so no specific recent developments can be cited. The company's financial performance and risk factors suggest a need for close monitoring of its liquidity and profitability in the coming periods.